PIK3CA mutations in lymphatic malformation may stimulate the expression of VEGF-C or VEGFR3, induce the binding of PIK3CA to the cellular membrane, or increase cell proliferation, chemotaxis, and angiogenesis through the activation of downstream Akt/mTOR. Here, AKT1 is linked to lymphatic malformation.